Live Breaking News & Updates on Waters Bioaccord System
Stay updated with breaking news from Waters bioaccord system. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
May 11 2021 Waters Corporation (NYSE:WAT) has introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists to monitor efficacy and safety through the analysis of critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and other protein-based drugs. “The BioAccord System moves attribute-based monitoring out of centralised MS labs and into the hands of more scientists in regulated and quality control laboratories who may not have extensive experience operating mass spectrometers,” said Jeff Mazzeo, Ph.D., Vice President – Global Marketing and Scientific Operations, Waters Corporation. “With this new method for the BioAccord System on the waters connect platform, scientists have a single, sensitive multiplexed method to accurately assess the most important attributes of protein-based drugs that enable rapid decision-making fo ....
Waters peptide multi-attribute method for BioAccord System boosts innovator and biosimilar drug development and commercialization selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.
Waters introduces new peptide multi-attribute method workflow biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
2 November 2020 Mass spectrometry (MS), once a technology empowering biotherapeutic characterization, is now a fundamental part of biopharma workflows for attribute-based analysis. This attribute monitoring role has application across the breadth of product and process development, and has expanded into manufacturing and quality organizations that have traditionally had limited experience with LC-MS. Find out how the Waters BioAccord System provides appropriate sensitivity, mass resolution and selectivity for directly analyzing biomolecules in the form of native proteins and protein complexes, denatured proteins, peptides, nucleic acids, and labeled glycans, providing biopharmaceutical organizations with deeper insights across drug development and commercial operations. The eBook covers the capabilities of the BioAccord LC-MS System across many biopharma-related applications, including: ....